Direct and Potent Regulation of γ-Secretase by Its Lipid Microenvironment*

γ-Secretase is an unusual and ubiquitous aspartyl protease with an intramembrane catalytic site that cleaves many type-I integral membrane proteins, most notably APP and Notch. Several reports suggest that cleavage of APP to produce the Aβ peptide is regulated in part by lipids. As γ-secretase is a multipass protein complex with 19 transmembrane domains, it is likely that the local lipid composition of the membrane can regulate γ-activity. To determine the direct contribution of the lipid microenvironment to γ-secretase activity, we purified the human protease from overexpressing mammalian cells, reconstituted it in vesicles of varying lipid composition, and examined the effects of individual phospholipids, sphingolipids, cholesterol, and complex lipid mixtures on substrate cleavage. A conventional γ-activity assay was modified to include a detergent-removal step to facilitate proteoliposome formation, and this increased baseline activity over 2-fold. Proteoliposomes containing sphingolipids significantly increased γ-secretase activity over a phosphatidylcholine-only baseline, whereas the addition of phosphatidylinositol significantly decreased activity. Addition of soluble cholesterol in the presence of phospholipids and sphingolipids robustly increased the cleavage of APP- and Notch-like substrates in a dose-dependent manner. Reconstitution of γ-secretase in complex lipid mixtures revealed that a lipid raft-like composition supported the highest level of activity compared with other membrane compositions. Taken together, these results demonstrate that membrane lipid composition is a direct and potent modulator of γ-secretase and that cholesterol, in particular, plays a major regulatory role.

[1]  B. Winblad,et al.  Active γ‐secretase is localized to detergent‐resistant membranes in human brain , 2008, The FEBS journal.

[2]  T. Hartmann,et al.  Alzheimer’s disease: the lipid connection , 2007, Journal of neurochemistry.

[3]  C. Haass,et al.  Amyloid Precursor Protein and Notch Intracellular Domains are Generated after Transport of their Precursors to the Cell Surface , 2006, Traffic.

[4]  D. Selkoe,et al.  γ-Secretase Substrate Selectivity Can Be Modulated Directly via Interaction with a Nucleotide-binding Site* , 2005, Journal of Biological Chemistry.

[5]  P. Schwille,et al.  Lipids as Modulators of Proteolytic Activity of BACE , 2005, Journal of Biological Chemistry.

[6]  B. Strooper,et al.  Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin , 2005, Nature Cell Biology.

[7]  T. Bonnert,et al.  Functional Overexpression of γ-Secretase Reveals Protease-independent Trafficking Functions and a Critical Role of Lipids for Protease Activity* , 2005, Journal of Biological Chemistry.

[8]  D. Selkoe,et al.  γ-Secretase Exists on the Plasma Membrane as an Intact Complex That Accepts Substrates and Effects Intramembrane Cleavage* , 2005, Journal of Biological Chemistry.

[9]  P. Wong,et al.  Association of γ-Secretase with Lipid Rafts in Post-Golgi and Endosome Membranes* , 2004, Journal of Biological Chemistry.

[10]  K. Beyreuther,et al.  GM1 ganglioside regulates the proteolysis of amyloid precursor protein , 2004, Molecular Psychiatry.

[11]  T. Kodama,et al.  Selective Reconstitution and Recovery of Functional γ-Secretase Complex on Budded Baculovirus Particles*[boxs] , 2004, Journal of Biological Chemistry.

[12]  Rong Wang,et al.  Purification and characterization of the human gamma-secretase complex. , 2004, Biochemistry.

[13]  Raphael Kopan,et al.  γ-Secretase: proteasome of the membrane? , 2004, Nature Reviews Molecular Cell Biology.

[14]  L. Horrocks,et al.  Neural membrane phospholipids in alzheimer disease , 1995, Neurochemical Research.

[15]  D. Selkoe,et al.  Inhibition of Receptor-mediated Endocytosis Demonstrates Generation of Amyloid β-Protein at the Cell Surface* , 2003, Journal of Biological Chemistry.

[16]  M. Mercken,et al.  Presenilin Redistribution Associated with Aberrant Cholesterol Transport Enhances β-Amyloid Production In Vivo , 2003, The Journal of Neuroscience.

[17]  Michael S. Wolfe,et al.  γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Regula,et al.  Reconstitution of γ-secretase activity , 2003, Nature Cell Biology.

[19]  Rudolph E. Tanzi,et al.  Alzheimer's disease: the cholesterol connection , 2003, Nature Neuroscience.

[20]  T. Iwatsubo,et al.  The role of presenilin cofactors in the γ-secretase complex , 2003, Nature.

[21]  D. Selkoe,et al.  Notch and the amyloid precursor protein are cleaved by similar gamma-secretase(s). , 2003, Biochemistry.

[22]  C. Haass,et al.  Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts , 2003, The Journal of cell biology.

[23]  D. Vance,et al.  Biochemistry of Lipids, Lipoproteins and Membranes , 2002 .

[24]  J. Rigaud.  Membrane proteins: functional and structural studies using reconstituted proteoliposomes and 2-D crystals. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[25]  R. Pepperkok,et al.  Inhibition of Intracellular Cholesterol Transport Alters Presenilin Localization and Amyloid Precursor Protein Processing in Neuronal Cells , 2002, The Journal of Neuroscience.

[26]  D. Selkoe,et al.  Activity-dependent isolation of the presenilin– γ-secretase complex reveals nicastrin and a γ substrate , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Younkin,et al.  Cholesterol-Dependent γ-Secretase Activity in Buoyant Cholesterol-Rich Membrane Microdomains , 2002, Neurobiology of Disease.

[28]  Xianlin Han,et al.  Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. , 2002, Biochemistry.

[29]  E. Kojro,et al.  Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Bergmann,et al.  Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[32]  H Jick,et al.  Statins and the risk of dementia , 2000, The Lancet.

[33]  G. Celesia,et al.  Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. , 2000, Archives of neurology.

[34]  Rong Wang,et al.  Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model , 2000, Neurobiology of Disease.

[35]  L. Horrocks,et al.  Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. , 2000, Chemistry and physics of lipids.

[36]  B. Strooper,et al.  Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Irma-Leena Notkola,et al.  Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease , 1998, Neuroepidemiology.

[38]  C. Masters,et al.  Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides , 1997, Nature Medicine.

[39]  P. Greengard,et al.  Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Gandy,et al.  The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry. , 1996, The Journal of biological chemistry.

[41]  B. Pitard,et al.  Reconstitution of membrane proteins into liposomes: application to energy-transducing membrane proteins. , 1995, Biochimica et biophysica acta.

[42]  E M Wijsman,et al.  Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease , 1995, Neurology.

[43]  M. Grant,et al.  Effect of Golgi membrane phospholipid composition on the molecular species of GM3 gangliosides synthesized by rat liver sialyltransferase. , 1994, Journal of lipid research.

[44]  C. Gottfries,et al.  Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II) , 1994, Journal of neurochemistry.

[45]  J. Growdon,et al.  Evidence for a membrane defect in Alzheimer disease brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Daniel Lévy,et al.  A systematic study of liposome and proteoliposome reconstitution involving Bio-Bead-mediated Triton X-100 removal. , 1990, Biochimica et biophysica acta.

[47]  G. Meer,et al.  Lipid traffic in animal cells , 1989 .

[48]  J. Hawthorne,et al.  Reduced Phosphoinositide Concentrations in Anterior Temporal Cortex of Alzheimer‐Diseased Brains , 1987, Journal of neurochemistry.

[49]  H. Sandermann.  Regulation of membrane enzymes by lipids. , 1978, Biochimica et biophysica acta.